- Home
- AWRE vs KZR Comparison
AWRE vs KZR Comparison
Compare AWRE & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AWRE | KZR |
|---|---|---|
| Founded | 1986 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.7M | 45.8M |
| IPO Year | 1996 | 2018 |
Fundamental Metrics
Financial Performance| Metric | AWRE | KZR |
|---|---|---|
| Price | $2.10 | $6.28 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 34.6K | ★ 37.4K |
| Earning Date | 10-29-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $17,428,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 2.72 | N/A |
| 52 Week Low | $1.37 | $3.53 |
| 52 Week High | $2.95 | $7.04 |
Technical Indicators
Market Signals| Indicator | AWRE | KZR |
|---|---|---|
| Relative Strength Index (RSI) | 42.66 | 61.40 |
| Support Level | $1.97 | $6.17 |
| Resistance Level | $2.22 | $6.37 |
| Average True Range (ATR) | 0.12 | 0.12 |
| MACD | 0.00 | -0.03 |
| Stochastic Oscillator | 32.52 | 75.00 |
Price Performance
Historical ComparisonAbout AWRE Aware Inc.
Aware Inc is a provider of software and services to the biometrics industry. The company's software products are used in government and commercial biometrics systems to identify or authenticate people. The government applications of biometrics systems include border control, visa applicant screening, law enforcement, national defense, intelligence, secure credentialing, access control, and background checks. Its commercial applications include user authentication for login to mobile devices, computers, networks, and software programs, user authentication for financial transactions and purchases. Its geographical segments include the United States, the United Kingdom, and the Rest of the world, out of which it derives maximum revenue from United States.
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.